Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.000
+0.075 (3.90%)
Sep 25, 2026, 2:53 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 10.9 million as of September 25, 2026. Its market cap has increased by 65.79% in one year.
Market Cap
10.90M
Enterprise Value
10.79M
Revenue
585.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
ChartMarket Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 10.90M, a decrease of -67.59%. That is a compound annual growth rate of -21.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 10.90M | 19.42% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IXICO | 16.42M |
| Oxford BioDynamics | 15.46M |
| SkinBioTherapeutics | 14.90M |
| Palatin Technologies | 14.56M |
| Fusion Antibodies | 14.02M |
| Aptamer Group | 11.23M |
| Solvonis Therapeutics | 8.17M |
| CRISM Therapeutics | 7.72M |